Exhibit 31.1 CERTIFICATION I, Stephen D. Newlin Exhibit 31.2 CERTIFICATION I, Robert M. Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C.

Review disclosures made to the Audit Committee by the Company’s CEO and CFO during their certification process for reports on Form 10-K and Form 10-Q about any significant deficiencies in the design or operation of internal controls and procedures or material weaknesses therein and 4 any fraud involving management or other employees who have a significant role in the Company’s internal controls and procedures. 10.

Exhibit 31.1 CERTIFICATION I, Robert M. Patterson Exhibit 31.2 CERTIFICATION I, Jamie A. Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C.

Seller warrants good and clear title in goods subject to the sale (“Product”) and that the Product con- forms at the time of shipment to a Certificate of Analysis, a Cer- tificate of Compliance, or a Product Specification Sheet, if any such document exists, and other specifications signed by Seller (“Specifications”). Säljaren garanterar att de produkter som är föremål för försäljningen (”Produkten”) är fria från rättsliga fel och att Produkten vid leveranstidpunkten stämmer överens med ett så kallat ”Certificate of Analysis”, ett ”Certificate of Compliance” eller ett ”Product Specification Sheet”, om något sådant existerar, och med andra specifikationer undertecknade av Säljaren (”Specifikationer”).

Wulfsohn      POLYONE CORPORATION68 Exhibit 31.1 CERTIFICATION I, Robert M. Richardson   POLYONE CORPORATION Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. POLYONE CORPORATION Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C.

Exhibit 31.1 CERTIFICATION I, Stephen D. Newlin Exhibit 31.2 CERTIFICATION I, Richard J. Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C.

They are formulated with  raw materials that are pre-tested to ISO, USP, EP and ICH Q3D protocols to mitigate the risk of product non-compliance of healthcare products.

Exhibit 31.1 CERTIFICATION I, Robert M. Patterson Exhibit 31.2 CERTIFICATION I, Jamie A. Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C.

Wulfsohn      POLYONE CORPORATION 67 Exhibit 31.1 CERTIFICATION I, Robert M. Richardson   POLYONE CORPORATION Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. POLYONE CORPORATION Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C.

Global Compact & fulfilled Communication of Progress (COP) requirements • New Sustainability Strategy overview page including our 2022 AIP ESG metrics • New ESG Performance page with ESG ratings, awards, and certifications • Increased disclosures on carbon emissions, including disclosure of Climate Change Scenario Analysis • Added new Product Stewardship and Chemical Management policies • Enhanced data reporting for Workforce Demographics • Improved social disclosures on human rights, dependent care and special leave and strategic training management 2021 SUSTAINABILITY REPORT Launching integrated sustainability website in parallel with report Aligned with leading reporting frameworks 9 ESG PERFORMANCE & AWARDS 10 84th ENVIRONMENTAL SOCIAL GOVERNANCE 1 3 (as of 6/30/22) 2022 O U TLO O K $429 $490 $3.05 $3.50 FY 2022 GUIDANCE (TOTAL COMPANY: CURRENT PORTFOLIO) 12 Sales Adjusted Operating Income $4,819 $5,100 + 6% Adjusted EPS + 14% + 15% (in millions) (in millions) (+ 9% excluding FX) (+ 18% excluding FX) (+ 20% excluding FX) 13 CASH FLOW / LEVERAGE ($ millions) 2022E Cash Flow from Operating Activities 400$ Less: Run-Rate CapEx (90) CapEx for Clariant Integration (10) CapEx for IT System Upgrade (15) Total CapEx (115) Free Cash Flow 285$ Adjusted EBITDA 635$ Net Debt / Adjusted EBITDA 1.6x 14 DYNEEMA / DISTRIBUTION UPDATES • Strong performance so far in 2022 in-line with our modeling • Acquisition to be finalized as early as September 1, pending standard regulatory process and closing conditions • Encouraging interest thus far from potential buyers for world-class business with a strong track record • Second round bids due in August DISTRIBUTION 15 PRO FORMA MODELING UPDATE 2022E ($M) Revenue 5,100$ 415$ 5,515$ (1,635)$ 3,880$ Adjusted EBITDA 635 130 765 (109) 656 EBITDA % 12% 31% 14% 7% 17% Adj.